View Older Stories View More Recent Stories
-
Atara Biotherapeutics to Participate in a Panel Discussion at the Citi 16th Annual BioPharma Virtual Conference
-
Citi Upgrades Atara Biotherapeutics (ATRA) to Buy
-
ATARA Biotherapeutics (ATRA) Prices 5.102M Share Common Offering at $24.50/Sh
-
Atara Biotherapeutics Announces Pricing of $175.0 Million Public Offering
-
Pre-Open Stock Movers 12/08: (LXRX) (SFIX) (SMAR) Higher; (PEN) (CONN) (MRNS) Lower (more...)
-
ATARA Biotherapeutics (ATRA) to Offer $150M of Common Stock
-
Atara Biotherapeutics Announces Proposed Offering of Common Stock
-
Atara Biotherapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
ATARA Biotherapeutics (ATRA) Prices 12.63M Share Common Offering at $11.32/Sh
-
Atara Biotherapeutics Announces Pricing of $175.5 Million Public Offering
-
ATARA Biotherapeutics (ATRA) Announces Proposed Common Share & Pre-Funded Warrants Offering
-
Atara Biotherapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
-
UPDATE: Citi Upgrades Atara Biotherapeutics (ATRA) to Buy
-
Atara Biotherapeutics to Participate in Citi 14th Annual Biotech Conference
-
Atara Biotherapeutics to Participate in Citi 14th Annual Biotech Conference
-
Atara Biotherapeutics (ATRA) PT Lowered to $14 at Citi
-
ATARA Biotherapeutics (ATRA) Prices 6.87M Share Common Offering at $15.28/Sh
-
Atara Biotherapeutics Announces Pricing of $150.0 Million Public Offering
-
Atara Biotherapeutics Announces Pricing of $150.0 Million Public Offering
-
ATARA Biotherapeutics (ATRA) Announces Proposed $125M Share Common Offering
-
Atara Biotherapeutics Announces Proposed Offering of Common Stock
-
Atara Biotherapeutics Announces Proposed Offering of Common Stock
-
Citi Upgrades Atara Biotherapeutics (ATRA) to Neutral
-
Atara Biotherapeutics (ATRA) PT Lowered to $23 at Citi
-
UPDATE: Citi Downgrades Atara Biotherapeutics (ATRA) to Sell
-
Pre-Open Movers 02/15: (AMAG) (SEDG) (TEVA) Higher; (CDMO) (THS) (NTAP) Lower (more...)
-
Citi Upgrades Atara Biotherapeutics (ATRA) to Neutral
-
Atara Biotherapeutics to Participate in Four Upcoming Investor Conferences
-
Atara Biotherapeutics to Participate in Three Upcoming Investor Conferences
-
Baupost Group 13F Shows New Stakes in Qualcomm (QCOM), Qorvo (QRVO), Express Scripts (ESRX) (More...)
-
Baupost Group 13F Shows New Stakes in Dell Technolgies (DVMT), NorthStar (NSAM), Office Depot (ODP), Increase in Twenty-First Century Fox (FOXA) (More...)
-
Baupost Group's 13F Shows New Stakes in Avis (CAR), Cascadian (CASC), Increase in Allergan (AGN) (More...)
-
Baupost Shows New Stake in La Quinta (LQ), Increases AIG (AIG), EMC (EMC), More ...
-
Baupost Group's 13F Shows New Stake in EMC Corp. (EMC), Raised Stake in Sunrun (RUN), Liquidated Alcoa (AA) ...
-
Citi Downgrades Atara Biotherapeutics (ATRA) to Sell
-
Unusual 11 Mid-Day Movers 12/14: (NRX) (FXCM) (TSL) Higher; (PN) (ATRA) (GPRO) Lower
-
Klarman's Baupost Group 13F Shows New Stakes in Alcoa (AA), Paypal (PYPL), Fox (FOXA), Olin (OLN) (more ...)
-
Atara Biotherapeutics Announces Participation in Three Investor Conferences
-
Atara Biotherapeutics, Inc. to Present at Upcoming Investor Conferences in September 2015
-
Klarman's Baupost Group Enters Frontier (FTR), Sanchez Energy (SN) (more...) - 13F
-
Atara Bio Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
ATARA Biotherapeutics (ATRA) Prices 3.46M Common Stock Offeirng at $52/Share
-
Atara Bio Announces Pricing of Its $180.0 Million Offering of Common Stock
-
Atara Biotherapeutics (ATRA) Announces $125M Common Stock Offering
-
Atara Bio Announces Proposed Offering of Common Stock
-
Klarman's Baupost Boosts AIG (AIG), Ocwen (OCN) Stakes, Lowers Veritiv (VRTV); Micron (MU), eBay (EBAY) Positions Maintained
-
Three Small Cap Biotech Stocks Added to Citi's Most Preferred List (ATRA) (NVAX) (PBYI)
-
Klarman's Baupost Shows New Stakes in Atara (ATRA), Forward Pharma (FWP), (more...)
-
Atara Biotherapeutics (ATRA) 3.64M Offering Prices at $18/Share
-
Atara Biotherapeutics (ATRA) IPO Opens Lower

